ROIVHIGH SIGNALFINANCIAL10-K

ROIV experienced a dramatic financial deterioration with operating income swinging from $4.2B profit to $1.0B loss while revenue collapsed 77% and cash reserves declined by $3.8B.

The company has undergone a massive financial transformation from highly profitable operations to significant losses, suggesting either a major business model shift, large one-time charges, or fundamental operational challenges. The language changes indicate management is now acknowledging sustained profitability concerns and potential future capital needs, marking a stark reversal from their previous commercial confidence.

Comparing 2025-05-29 vs 2024-05-30View on EDGAR →
FINANCIAL ANALYSIS

ROIV's financials show a company in dramatic transition, with operating performance collapsing from $4.2B profit to $1.0B loss alongside a 77% revenue decline, while the company burned through $3.8B in cash reserves. The massive 1,177% inventory increase to $35.3M suggests either significant operational scaling or potential write-down risks, while total liabilities decreased substantially by 68% to $249.7M. Overall, the financial picture reveals a company that has moved from exceptional profitability to significant losses while consuming substantial cash, indicating either major strategic restructuring or serious operational challenges that investors should monitor closely.

FINANCIAL STATEMENT CHANGES
Inventory
Balance Sheet
+1176.7%
$2.8M$35.3M

Inventory surged 1176.7% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Capital Expenditure
Cash Flow
+232.8%
$1.4M$4.6M

Capital expenditure jumped 232.8% — major investment cycle underway; assess returns on deployment.

Operating Income
P&L
-123.7%
$4.2B-$1.0B

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-104%
$4.3B-$172.0M

Net income declined 104% — review whether driven by operations, interest costs, or non-recurring items.

Revenue
P&L
-76.7%
$124.8M$29.1M

Revenue declined 76.7% — significant demand weakness or market share loss warrants investigation.

Total Liabilities
Balance Sheet
-67.7%
$774.0M$249.7M

Liabilities reduced 67.7% — deleveraging improves balance sheet strength and financial flexibility.

Cash & Equivalents
Balance Sheet
-58.5%
$6.5B$2.7B

Cash declined 58.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Current Liabilities
Balance Sheet
-44%
$266.8M$149.4M

Current liabilities reduced — improved short-term financial position and working capital health.

Current Assets
Balance Sheet
-25.7%
$6.7B$5.0B

Current assets declined 25.7% — monitor working capital adequacy and short-term liquidity.

Total Assets
Balance Sheet
-24.7%
$7.2B$5.4B

Total assets contracted 24.7% — asset sales, write-downs, or balance sheet optimization underway.

LANGUAGE CHANGES
NEW — 2025-05-29
PRIOR — 2024-05-30
ADDED
As of May 21, 2025 there were 679,806,070 common shares outstanding.
We will likely incur significant operating losses for the foreseeable future and may never achieve sustained profitability.
We face risks associated with acquisitions, divestitures and other strategic transactions.
We face risks associated with the use of our cash, cash equivalents and marketable securities.
We are exposed to risks related to our significant holdings of cash, cash equivalents and marketable securities.
+7 more — sign up free →
REMOVED
As of May 28, 2024 there were 738,721,807 common shares outstanding.
We have generated limited revenue from our operations since inception, and there is no guarantee that we will generate significant revenues in the future.
We have relatively limited experience as a commercial-stage company and the marketing and sale of VTAMA (tapinarof) or any future products may be unsuccessful or less successful than anticipated.
Our business is dependent to a significant extent on the successful commercialization of VTAMA and the development, regulatory approval and commercialization of our current and future products and product candidates.
We may engage in strategic transactions that could impact our liquidity, increase our expenses and present significant distractions to our management.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →